Latest Supply Chains News

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

X2M Connect has signed a non-binding two-year MOU with Gateway DC covering data centre development, delivery and platform deployment across Australia and potentially Southeast Asia. The opportunity links Gateway’s planned 120MW-to-2GW-plus Darwin roadmap with X2M’s prospective pipeline exceeding 200MW, but revenue remains subject to future binding agreements.

Anson Resources has signed a non-binding MoU covering a potential five-year lithium carbonate offtake with Wogen and possible project financing support from Xcelsior. The proposed supply could reach 6,000 tonnes of lithium carbonate equivalent a year, but deliveries remain dependent on Green River being financed, permitted and built.

Telix will acquire ITM in a proposed US$1.65 billion deal that combines a commercial radioisotope supplier with Telix’s precision medicine and therapeutic pipeline. The transaction could give Telix greater supply-chain control and entry into a validated cancer treatment market, but it also brings dilution, integration risk and an unresolved FDA pathway for ITM-11.

Vulcan Energy has started commercial-scale production in Germany of VULSORB, the proprietary adsorbent at the centre of its planned direct lithium extraction process. The material will supply first-fill volumes for Project Lionheart, although lithium production remains targeted for the second half of 2028.

American Tungsten & Antimony has produced antimony ingot from Arizona-mined material at its Nevada refinery, providing the first physical demonstration of its proposed US mine-to-metal chain. The milestone creates samples for testing and customer qualification, but the underlying asset acquisition remains incomplete and product quality is yet to be disclosed.

Globe International increased FY2026 EBIT and net profit despite almost no revenue growth, as a tighter brand portfolio improved margins across all three regions. The ASX-listed group also lifted its fully franked annual dividend to 23 cents per share and ended the year with A$26.7 million in cash.

CurveBeam AI has raised A$1.75 million through an oversubscribed SPP shortfall offer and placement, lifting its recent capital raised to A$7.36 million. The funds will support the HiRise China launch, product development, supply-chain preparation and working capital.

Austco Healthcare delivered record FY26 revenue and statutory profit, with stronger margins, cash generation and a modest recovery in contracted orders entering the new financial year. The company is pairing that momentum with further reseller consolidation, including the $2.88 million acquisition of Medical Communications Systems.

Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.

Rox Resources has crossed the line from explorer to mine developer, with Youanmi underground mining underway, the processing plant under construction and a target of first gold in mid-2027. The project is financed on paper, but the A$350 million debt package remains subject to conditions precedent and the construction schedule still has to survive execution.